Pamela Wapnick
Directeur Financier/CFO chez METAGENOMI, INC.
Fortune : 467 190 $ au 30/04/2024
Profil
Pamela Wapnick is currently the Chief Financial Officer at Metagenomi, Inc. She has previously worked as Vice President-Finance at Amgen, Inc. and as Chief Financial Officer at Graybug Vision, Inc., True North Therapeutics, Inc., Metagenomi Technologies LLC, and Capsida Biotherapeutics, Inc. She received her undergraduate degree from Wellesley College and her MBA from Columbia Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
METAGENOMI, INC.
0,18% | 01/04/2024 | 69 316 ( 0,18% ) | 467 190 $ | 30/04/2024 |
Postes actifs de Pamela Wapnick
| Sociétés | Poste | Début |
|---|---|---|
| METAGENOMI, INC. | Directeur Financier/CFO | 01/09/2023 |
Anciens postes connus de Pamela Wapnick
| Sociétés | Poste | Fin |
|---|---|---|
Diality, Inc.
 Diality, Inc. Medical SpecialtiesHealth Technology Diality, Inc. is engaged in manufacturing medical devices. The company is headquartered in Irvine, CA. | Directeur Financier/CFO | 01/09/2023 |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Directeur Financier/CFO | 01/06/2022 |
| CALCIMEDICA, INC. | Directeur Financier/CFO | 01/10/2019 |
| AMGEN INC. | Directeur Financier/CFO | 01/03/2016 |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Directeur Financier/CFO | - |
Formation de Pamela Wapnick
| Wellesley College | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| METAGENOMI, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Commercial Services |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
Diality, Inc.
Diality, Inc. Medical SpecialtiesHealth Technology Diality, Inc. is engaged in manufacturing medical devices. The company is headquartered in Irvine, CA. | Health Technology |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Health Technology |
